Praktické lékárenství – 2/2020

www.praktickelekarenstvi.cz e43 AKTUÁLNÍ FARMAKOTERAPIE Hypertenze jako nežádoucí účinek léčiv PRAKTICKÉ LÉKÁRENSTVÍ 15. Eisen T, Sternberg CN, et al. Targeted Therapies for Renal Cell Carcinoma: Review of Ad- verse Event Management Strategies. J Natl Cancer Inst 2012; 104: 93–113. 16. Boughton Ch, Taylor D, et al. Mineralocorticoid hypertension and hypokalaemia indu- ced by posaconazole. Endocrinol Diabetes Metab Case Rep. 2018; 17–0157. 17. Auchusa RJ, Yub MK, et al. Use of Prednisone With Abiraterone Acetate in Metastatic Castration‑Resistant Prostate Cancer. The Oncologist 2014; 19: 1231–1240. 18. Grossman A, Messerli FH, et al. Drug induced hypertension – An unappreciated cause of secondary hypertension. European Journal of Pharmacology. 2015; 763: 15–22. 19. Gyamlani G, Gerac SA.,Secondary Hypertension due to Drugs and Toxins. Southern Me- dical Journal. 2007; 7(100): 692−699.